| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.
|
J Clin Microbiol
|
2003
|
8.25
|
|
2
|
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
|
J Clin Microbiol
|
2005
|
7.91
|
|
3
|
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.
|
PLoS Pathog
|
2007
|
4.82
|
|
4
|
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.
|
AIDS
|
2006
|
2.71
|
|
5
|
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
|
Blood
|
2008
|
2.27
|
|
6
|
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.
|
J Clin Invest
|
2005
|
1.96
|
|
7
|
Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
|
AIDS
|
2010
|
1.90
|
|
8
|
Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.
|
J Virol
|
2009
|
1.84
|
|
9
|
Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
|
J Acquir Immune Defic Syndr
|
2003
|
1.82
|
|
10
|
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation.
|
Blood
|
2004
|
1.82
|
|
11
|
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
|
J Clin Invest
|
2005
|
1.82
|
|
12
|
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters.
|
J Infect Dis
|
2003
|
1.65
|
|
13
|
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.
|
J Infect Dis
|
2001
|
1.54
|
|
14
|
Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans.
|
Blood
|
2007
|
1.52
|
|
15
|
Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen.
|
J Immunol
|
2003
|
1.42
|
|
16
|
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.
|
J Infect Dis
|
2004
|
1.37
|
|
17
|
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.
|
J Virol
|
2008
|
1.36
|
|
18
|
Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
|
J Virol
|
2006
|
1.32
|
|
19
|
Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.
|
PLoS One
|
2012
|
1.31
|
|
20
|
Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection.
|
J Immunol
|
2007
|
1.29
|
|
21
|
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
|
J Virol
|
2006
|
1.25
|
|
22
|
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.
|
J Virol
|
2006
|
1.24
|
|
23
|
Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.
|
J Virol
|
2008
|
1.20
|
|
24
|
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
|
J Virol
|
2009
|
1.19
|
|
25
|
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.
|
Blood
|
2002
|
1.18
|
|
26
|
HIV populations are large and accumulate high genetic diversity in a nonlinear fashion.
|
J Virol
|
2013
|
1.17
|
|
27
|
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.
|
Hum Gene Ther
|
2005
|
1.17
|
|
28
|
Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.
|
Proc Natl Acad Sci U S A
|
2002
|
1.12
|
|
29
|
Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.
|
J Virol
|
2003
|
1.06
|
|
30
|
Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples.
|
Clin Infect Dis
|
2010
|
1.03
|
|
31
|
CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation.
|
J Infect Dis
|
2007
|
1.02
|
|
32
|
Interferon-alpha produces significant decreases in HIV load.
|
J Interferon Cytokine Res
|
2010
|
0.99
|
|
33
|
Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy.
|
J Acquir Immune Defic Syndr
|
2006
|
0.98
|
|
34
|
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.
|
AIDS
|
2004
|
0.96
|
|
35
|
Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience.
|
AIDS Patient Care STDS
|
2011
|
0.95
|
|
36
|
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.
|
J Infect Dis
|
2009
|
0.90
|
|
37
|
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.
|
AIDS
|
2003
|
0.89
|
|
38
|
The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.
|
PLoS One
|
2013
|
0.88
|
|
39
|
Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.
|
J Acquir Immune Defic Syndr
|
2003
|
0.87
|
|
40
|
Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy.
|
AIDS Res Hum Retroviruses
|
2002
|
0.87
|
|
41
|
Effects of delays in peripheral blood processing, including cryopreservation, on detection of CD31 expression on naive CD4 T cells.
|
Clin Vaccine Immunol
|
2008
|
0.83
|
|
42
|
Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness.
|
J Virol
|
2006
|
0.82
|
|
43
|
HIV-1 infected monozygotic twins: a tale of two outcomes.
|
BMC Evol Biol
|
2011
|
0.81
|
|
44
|
Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individuals.
|
HIV Clin Trials
|
2004
|
0.80
|
|
45
|
Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load.
|
J Clin Microbiol
|
2007
|
0.80
|
|
46
|
Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis.
|
AIDS
|
2004
|
0.77
|
|
47
|
Evaluation of a single-platform technology for lymphocyte immunophenotyping.
|
Clin Vaccine Immunol
|
2007
|
0.76
|
|
48
|
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
|
J Infect Dis
|
2003
|
0.76
|
|
49
|
Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients.
|
Clin Diagn Lab Immunol
|
2005
|
0.75
|